Robert Kramer
2021 - Emergent BioSolutions
Compensation breakdown
Non-Equity Incentive Plan | $900,000 |
---|---|
Option Awards | $2,198,742 |
Salary | $1,026,924 |
Stock Awards | $2,800,026 |
Other | $6,385 |
Total | $6,932,076 |
Kramer received $2.8M in stock awards, accounting for 40% of the total pay in 2021.
Kramer also received $900K in non-equity incentive plan, $2.2M in option awards, $1M in salary and $6.4K in other compensation.
Rankings
In 2021, Robert Kramer's compensation ranked 1,776th out of 12,415 executives tracked by ExecPay. In other words, Kramer earned more than 85.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,776 out of 12,415 | 86th |
Division Manufacturing | 656 out of 5,508 | 88th |
Major group Chemicals And Allied Products | 244 out of 2,378 | 90th |
Industry group Drugs | 206 out of 2,099 | 90th |
Industry Pharmaceutical Preparations | 140 out of 1,549 | 91st |
Pay ratio
Robert Kramer's Pay | $6,932,076 |
---|---|
Median Employee's Pay | $110,416 |
Pay Ratio | 63to 1 |
In 2021, the annual total compensation of Robert Kramer was $6,932,076.
The annual total compensation of the median employee at Emergent BioSolutions was $110,416.
The ratio of Robert Kramer's pay to the pay of median employee was therefore 63 to one.
Kramer's colleagues
We found four more compensation records of executives who worked with Robert Kramer at Emergent BioSolutions in 2021.
News
April 15, 2022
April 9, 2021
April 28, 2020
April 9, 2020
April 26, 2019